Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Accuracy of Hemoglobin A1C to Predict Glycemia in HIV

View source ↗

Summary

This clinical trial assesses whether Hemoglobin A1C can accurately predict glycemia in people with HIV, including those with diabetes. The study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV, Diabetes | Status: COMPLETED